what are all the glp-1 drugs medications get at heart of addiction: study – WashU Medicine America's Poison Centers - GLP-1

Furthermore, as these therapies are primarily injectable (with the exception of oral semaglutide), ensuring long-term patient adherence can be a challenge, requiring robust patient education, support systems, and simpler delivery devices

Nevertheless, concerning case reports and retrospective studies have emerged in 2023 of undigested gastric contents in sedated/anaesthetised patients undergoing elective endoscopy with unprotected airways: Klein and Hobai (2023) published a case report of a patient taking semaglutide for weight loss who experienced pulmonary aspiration from undigested food content identified during routine gastroscopy, despite fasting 18hr prior to the procedure

A combined drug delivery system is a novel method that combines two or more therapeutically active agents, such as biologics and small molecules, into a single formulation

Reported results include: 0% vomiting at the most effective dose Discontinuation due to adverse events similar to placebo Gastrointestinal events mostly mild That said, an important nuance: While vomiting was reported as 0%, nausea was still observed, although mostly mild